AAHRPP Releases 2010 Metrics on Human Research Protection Programs Performance
Improving the quality of human research protection programs is a top priority for AAHRPP. Effective and efficient systems of oversight within organizations provide better protections for research participants and produce higher quality research. And collectively, they raise the bar globally to ensure research participants are safe and respected.
From data supplied by client organizations in 2010, AAHRPP has compiled an information database to help research organizations, researchers, sponsors, government agencies, and participants identify and support high-performing practices for human research protection programs (HRPPs).
Published here are the 2010 metrics for HRPP performance. The data range from types of research and conformance with regulations and guidance to financial and personnel resources and IRB review times.
A PDF version of the 2010 metrics will be available shortly. The 2009 metrics are available on the Website here.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
